BCYC - Company ID 0001761612
BICYCLE THERAPEUTICS plc trades as BCYC. In its fiscal 2025 annual report the company posted revenue of $72.59M, up 105.8% from the prior year and net income of -$218.96M. This page tracks BICYCLE THERAPEUTICS plc through 628 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 8 fiscal years BICYCLE THERAPEUTICS plc's revenue grew from $2.06M to $72.59M, a compound annual growth rate of 56.1%. Net profit margin expanded from -789.3% to -301.7% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-21 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| SCHEDULE 13G | - | 2026-05-15 |
| SCHEDULE 13G/A | - | 2026-05-04 |
| Quarterly report | 10-Q | 2026-04-30 |
| Major company event | 8-K | 2026-04-30 |
| Annual report to shareholders | ARS | 2026-04-22 |
| Proxy statement | DEF 14A | 2026-04-22 |
The largest companies sharing BICYCLE THERAPEUTICS plc's SEC industry classification (pharmaceutical preparations).
BICYCLE THERAPEUTICS plc reported revenue of $72.59M for fiscal year 2025, an increase of 105.8% year over year.
In its latest fiscal year BICYCLE THERAPEUTICS plc reported a net loss of $218.96M.